Molecule Details
InChIKeyHUFOZJXAKZVRNJ-UHFFFAOYSA-N
Compound NameRociletinib
Canonical SMILESC=CC(=O)Nc1cccc(Nc2nc(Nc3ccc(N4CCN(C(C)=O)CC4)cc3OC)ncc2C(F)(F)F)c1
Clinical Status Data-mined Candidate
Targets (Human+Pathogen)10
Pfam Stratification Cross-Family
Avg pChEMBL6.73
SourceBindingDB;ChEMBL
2D Structure
2D structure
Activity Profile
DrugBank Annotations
DrugBank ID DB11907
Drug NameRociletinib
CAS Number1374640-70-6
Groups investigational
ATC Codes L01EB05
DescriptionRociletinib has been used in trials studying the treatment and prevention of Nonsmall Cell Lung Cancer, Non-small Cell Lung Cancer, and Locally Advanced or Metastatic Non-small Cell Lung Cancer.

Categories: Acids, Acyclic Acrylates Amides Antineoplastic Agents Antineoplastic and Immunomodulating Agents Epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors Protein Kinase Inhibitors
Cross-references: BindingDB: 149404 CHEMBL3545308 ChemSpider: 30646712 PDB: 8JC PubChem:57335384 PubChem:347828240 Wikipedia: Rociletinib ZINC: ZINC000098043800
Target Activities (10)
Target Gene Organism Category Pfam pChEMBL Type Source
P00533 EGFR Homo sapiens Human PF00757 PF14843 PF07714 PF01030 PF21314 7.7 IC50 ChEMBL;BindingDB
P21860 ERBB3 Homo sapiens Human PF00757 PF14843 PF07714 PF01030 7.3 IC50 ChEMBL;BindingDB
P04626 ERBB2 Homo sapiens Human PF00757 PF14843 PF07714 PF01030 PF21314 7.2 IC50 BindingDB
Q9UM73 ALK Homo sapiens Human PF12810 PF00629 PF07714 6.8 IC50 ChEMBL;BindingDB
P42680 TEC Homo sapiens Human PF00779 PF00169 PF07714 PF00017 PF00018 6.5 Kd ChEMBL
Q13470 TNK1 Homo sapiens Human PF07714 PF22931 6.5 Kd ChEMBL
Q05397 PTK2 Homo sapiens Human PF21477 PF00373 PF18038 PF03623 PF07714 6.4 Kd ChEMBL
O14976 GAK Homo sapiens Human PF00069 PF10409 6.3 Kd ChEMBL
Q06187 BTK Homo sapiens Human PF00779 PF00169 PF07714 PF00017 PF00018 6.3 Kd ChEMBL
P49759 CLK1 Homo sapiens Human PF00069 6.2 Kd ChEMBL
DrugBank Target Actions (1)
Target Gene Target Name Action Type
P00533 EGFR Epidermal growth factor receptor modulator targets